New Horizons in Cardiomyopathy 2025

  • Published:  28 February 2025
  • Views: 

    Views Icon

    1502

  • Likes: 

    Heart Icon

    3

Up Next

New Horizons in Cardiomyopathy 2025

  • Published:  28 February 2025
  • Views: 

    Views Icon

    1502

  • Likes: 

    Heart Icon

    3

Average (ratings)
No ratings
Your rating
About the episode

Presentations

  • Case Study Presentation
  • When Do You Suspect Cardiomyopathy?
  • Overview of the Diagnostic Pathway
Overview

Radcliffe Cardiology was proud to host New Horizons in Cardiomyopathy 2025 (NHC), specially focused on cardiac amyloidosis and cardiomyopathy diagnosis and treatment.  

 

Day 1 focused on hypertrophic cardiomyopathy (HCM), with a detailed exploration of HCM and an emphasis on emerging therapies and management strategies. Day 2 focused on amyloidosis, providing a comprehensive update on the diagnosis and treatment of cardiac amyloidosis, along with insights into the latest research and clinical practices.

 

The course directors, Prof Rodney Falk (Brigham and Women’s Hospital, US), Prof Perry Elliott (University College London, UK), and Prof Marianna Fontana (University College London, UK), led a distinguished group of faculty members who are renowned experts in the field of cardiac amyloidosis and HCM. 
 

NHC was designed to educate healthcare professionals on the evolving management practices in cardiac amyloidosis and cardiomyopathy in an informal and engaging learning environment featuring thought-provoking presentations, cases and practical masterclasses.

 

 *Please note, the live version of New Horizons in Cardiomyopathy was accredited. The on-demand version is not.

AstraZeneca and Bayer have provided a grant towards this independent project and has had no involvement in its creation or organisation.

Learning Objectives

  • Increase the awareness of at-risk patients
  • Improve understanding of screening procedures
  • Provide guidance on the use of imaging for diagnosis
  • Improve awareness on current and emerging treatment
  • Provide guidance on initiating treatment and managing comorbidities

Target Audience

  • Cardiologists (device implanters, heart failure)
  • Imaging Specialists
  • Electrophysiologists
  • Primary Care
  • Haematologists
  • Cardiac Nurse Practitioners

More from this programme

Part 1

Day 1: Session 1 – The Cardiomyopathy Mindset

In this opening session of NHC, presentations cover the basics of cardiomyopathy diagnosis, including when to suspect it and overview of the diagnostic pathway. The faculty present on clinical indicators for suspicion and discuss case studies. 

Part 2

Day 1: Session 2 – The Diagnostic Pathway

Session 2 focuses on the diagnostic pathway. Faculty discuss assessing the ventricular function in the diagnosis of cardiomyopathy, diagnostic tools and phenotyping.

Part 3

Day 1: Session 3 – The Management of Cardiomyopathy

This session highlights the critical role of risk stratification and prognostic assessment in the management of hypertrophic cardiomyopathy. The discussion also delves into the management strategies tailored to hypertrophic cardiomyopathy patients through a case study approach. 

Part 4

Day 2: Session 1 – Amyloidosis Specific Diagnosis

This session covers amyloidosis diagnosis, featuring a case study on key clinical clues. It explores scintigraphy challenges and CMR imaging's role in cardiac amyloidosis.

Part 5

Day 2: Session 2 – Implementation in Practice

The faculty dive into a complex case, examining the challenges of both diagnosing and managing a patient, providing valuable insights into navigating such multifaceted scenarios.

Part 6

Day 2: Session 3 – Phenotyping Management Strategies

This session focuses on phenotyping management strategies for amyloidosis. The faculty discuss collaborating with haematologists to address cardiac complexities and complications that arise during chemotherapy. 

Part 7

Day 2: Session 4 – The Treatment Horizon

In the final session of the event, faculty provide an overview of recently completed and on-going trials.

Faculty Biographies

Marianna Fontana

Marianna Fontana

Professor of Cardiology and Honorary Consultant Cardiologist

Prof Marianna Fontana is Professor of Cardiology and Honorary Consultant Cardiologist at the National Amyloidosis Centre, Division of Medicine, University College London, London, UK.

Her main clinical and research interests include the delivery of efficient and effective care for patients with amyloidosis, with a particular focus on new technologies.

View full profile
Perry Elliott

Perry Elliott

Professor in Inherited Cardiovascular Disease

Personal History

Professor Perry Mark Elliott was born on December 7, 1963, in London.6 He is a Professor of Cardiovascular Medicine at University College London (UCL) and a Senior Investigator of the UK National Institute for Health Research (NIHR). 

He is Director of the UCL Centre for Heart Muscle Disease, Head of Clinical Research at the Institute of Cardiovascular Science UCL and a consultant cardiologist in the Centre for Inherited Cardiovascular Disease at the Barts Heart Centre, St. Bartholomew's Hospital London, UK.3

Academic History1

Dr Elliott studied medicine at St. Thomas’s Hospital Medical School, London from 1982 to 1987.

After graduating in 1987 he trained in general medicine. In 1991 he became a member of the Royal College of Physicians and completed his general cardiology training at St. George’s Hospital Medical School, London.

His…

View full profile
Elena Arbelo

Elena Arbelo

Associate Professor

Prof Elena Arbelo is a Cardiac Electrophysiologist at Hospital Clínic of Barcelona, Barcelona, Spain, where she serves as Coordinator of the Cardiac Genetic Diseases and Sudden Arrhythmic Death Unit.

She is a Clinical Professor at the University of Barcelona and a researcher at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Prof Arbelo is a member of several committees of the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA), and the Heart Rhythm Society (HRS).

Prof Arbelo is a committee member for several large-scale European Registries to gather data on atrial fibrillation and guideline implementation. She serves as a member of the Working Group on Atrial Fibrillation of the International Consortium for Health Outcomes Measurement (ICHOM). 

Prof Arbelo is an editorial board member of Arrhythmia & Electrophysiology Review journal. 

 

View full profile
Caroline Coats

Caroline Coats

Honorary Clinical Senior Lecturer

Dr Caroline Coats is an Honorary Clinical Senior Lecturer at the University of Glasgow, Glasgow, UK. 

Dr Coats leads the West of Scotland Inherited Cardiac Conditions Service. She was awarded a Career Researcher Fellowship from the Chief Scientific Office and serves as Principal Investigator for several global clinical trials. 

View full profile
Sanjay  Sharma

Sanjay Sharma

Prof Sharma qualified in the UK in 1989 and was appointed Consultant Cardiologist and Physician at University Hospital Lewisham. In 2006, he took up the post of Director of Heart Muscle Diseases at Kings College London and was promoted to Professor of Cardiology at St George’s University of London in 2010.

He is medical director for Virgin London Marathon, consultant cardiologist for the CRY sports cardiology clinic at St George’s Hospital, and cardiologist for the English Institute of Sport, British Rugby League and the British Lawn Tennis Association.

Dr Sanjay Sharma is on the Editorial Board of European Cardiology Review.

View full profile